Stereotaxis STXS
NYSE STXS
$1.42 -0.02 (-1.39%)
At close: Aug 21, 2026 · 4:00 PM EDT

Stereotaxis (STXS) Cash from Financing Activities (2010 - 2026)

Stereotaxis (STXS) posted quarterly Cash from Financing Activities of $4.7 million for Q1 2026, up 14637.5% year-over-year from N/an in Q1 2025, and down 32.18% quarter-over-quarter from $7.0 million in Q4 2025.

Stereotaxis (STXS) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Stereotaxis (STXS) has reported Cash from Financing Activities for 17 consecutive years, with $4.7 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash from Financing Activities rose 14637.5% year-over-year to $4.7 million; the TTM figure through Mar 2026 stood at $19.4 million (up 6404.01% YoY), while the FY2025 annual figure was $14.8 million, up 4870.71% from the prior year.
  • Cash from Financing Activities fell to $4.7 million in Q1 2026 per STXS's latest filing, from $7.0 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $7.7 million in Q3 2025 and bottomed at -$26000.0 in Q2 2023.
  • Historically, Cash from Financing Activities has averaged $1.2 million across 5 years, with a median of $54000.0 in 2022.
  • Annual changes were most pronounced in 2023 — Cash from Financing Activities slumped 145.61% — and 2026, when it surged 14637.5%.
  • Stereotaxis' Cash from Financing Activities stood at $61000.0 in 2022, then plunged by 57.38% to $26000.0 in 2023, then jumped by 511.54% to $159000.0 in 2024, then surged by 4273.58% to $7.0 million in 2025, then plunged by 32.18% to $4.7 million in 2026.
  • Business Quant data shows STXS's Cash from Financing Activities at $4.7 million in Q1 2026, $7.0 million in Q4 2025, and $7.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn -287.90 Mn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn -577.00 Mn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -510.00 Mn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn -263.16 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn -159.00 Mn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn -164.80 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn -300.00 Mn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -75.80 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn -31.00 Mn
10 Stereotaxis 141.91 Mn 127.29 Mn 3.79 Mn 4.72 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.72 Mn
Mar 31, 2026 4.72 Mn
Dec 31, 2025 6.95 Mn
Dec 31, 2025 6.95 Mn
Sep 30, 2025 7.74 Mn
Sep 30, 2025 7.74 Mn
Jun 30, 2025 34,000.00
Jun 30, 2025 34,000.00
Mar 31, 2025 32,000.00
Mar 31, 2025 32,000.00
Dec 31, 2024 159,000.00
Dec 31, 2024 159,000.00
Sep 30, 2024 80,000.00
Sep 30, 2024 80,000.00
Jun 30, 2024 28,000.00
Jun 30, 2024 28,000.00
Mar 31, 2024 30,000.00
Mar 31, 2024 30,000.00
Dec 31, 2023 26,000.00
Dec 31, 2023 26,000.00